
Sign up to save your podcasts
Or


We examine the role of residual IRF and SRF in visual acuity results in treating nAMD. Dr. David Eichenbaum of Retina Vitreous Associates of Florida, Collaborative Associate Professor University of South Florida reviews the results of the Hawk and Harrier trials.
By Retina Synthesis4.5
88 ratings
We examine the role of residual IRF and SRF in visual acuity results in treating nAMD. Dr. David Eichenbaum of Retina Vitreous Associates of Florida, Collaborative Associate Professor University of South Florida reviews the results of the Hawk and Harrier trials.

43 Listeners

18 Listeners

100 Listeners

113,121 Listeners

56,944 Listeners

5 Listeners

9,556 Listeners

11 Listeners

47,718 Listeners

51 Listeners

11 Listeners

470 Listeners

19 Listeners

0 Listeners